The Training Program in Cancer Biology is a program for pre- and postdoctoral trainees designed to train investigators who will focus on biological and chemical issues specifically related to the problem of cancer during their research careers. This program imparts to trainees an understanding of the relationships between the basic scientific problems and clinical issues of human cancer. The Program is anchored in the Department of Cancer Biology of the Wake Forest University Comprehensive Cancer Center; all training faculty are either primary Cancer Biology Department members or are cross-appointed in Cancer Biology. Cross appointees come from the Departments of Biochemistry, Chemistry, Dermatology, Genomics, Microbiology, Pathology, Radiation Biology, and Surgery. Trainees include pre-doctoral Ph.D. candidates and Ph.D. or M.D. postdoctoral fellows who wish to supplement their training in cancer research. All pre-doctoral trainees are candidates for a Ph.D. in Cancer Biology conferred by the Graduate School of Wake Forest University. Pre- and postdoctoral traineeships combine research, seminar/symposia participation plus didactic coursework covering DNA damage and repair, cancer cell biology, signal transduction, cell cycle control, biochemical pharmacology, tumor immunology, gene therapy bioinformatics, and an overview of clinical and epidemiologic issues in human cancer. Research is supervised by Departmental faculty mentors; specific assignments are made by the Program executive committee. Key features of the Training Program include an extensive mentoring and evaluation process and a training faculty with active research programs that mesh clinical and basic science. This training program addresses the goals of the National Cancer Institute by: (1) producing investigators equipped to focus on the cancer problem in their research careers; (2) providing education spanning the chemical-biological interface; (3) emphasizing links between basic science and the clinical problems of human cancer. The Training Program achieved some notable successes during its initial funding cycle that will be carried forth into the current funding cycle, including: (1) markedly increasing the enrollment of under-represented minority trainees; (2) graduating postdoctoral trainees who have gone on to faculty positions at academic institutions; (3) providing biological training for two postdoctoral chemists and training in chemistry for two predoctoral Cancer Biology trainees.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA079448-09
Application #
7367122
Study Section
Subcommittee G - Education (NCI)
Program Officer
Myrick, Dorkina C
Project Start
2000-03-15
Project End
2010-02-28
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
9
Fiscal Year
2008
Total Cost
$491,121
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Biology
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Blischak, Paul D; Chifman, Julia; Wolfe, Andrea D et al. (2018) HyDe: A Python Package for Genome-Scale Hybridization Detection. Syst Biol 67:821-829
Swanner, Jessica; Singh, Ravi (2018) Synthesis, Purification, Characterization, and Imaging of Cy3-Functionalized Fluorescent Silver Nanoparticles in 2D and 3D Tumor Models. Methods Mol Biol 1790:209-218
Chmielewski, Jeffrey P; Bowlby, Sarah C; Wheeler, Frances B et al. (2018) CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools. Mol Cancer Res 16:1687-1700
Sirkisoon, Sherona R; Carpenter, Richard L; Rimkus, Tadas et al. (2018) Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer. Oncogene 37:2502-2514
Rimkus, Tadas K; Carpenter, Richard L; Sirkisoon, Sherona et al. (2018) Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44. Cancer Res 78:2589-2600
Chifman, Julia; Arat, Seda; Deng, Zhiyong et al. (2017) Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling Perspective. PLoS Comput Biol 13:e1005352
Nickkholgh, Bita; Sittadjody, Sivanandane; Rothberg, Michael B et al. (2017) Beta-catenin represses protein kinase D1 gene expression by non-canonical pathway through MYC/MAX transcription complex in prostate cancer. Oncotarget 8:78811-78824
Carpenter, Richard L; Sirkisoon, Sherona; Zhu, Dongqin et al. (2017) Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth. Oncotarget 8:73947-73963
Alexander, Peter M; Caudell, David L; Kucera, Gregory L et al. (2017) The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia. PLoS One 12:e0179798
Eldridge, Brittany N; Xing, Fei; Fahrenholtz, Cale D et al. (2017) Evaluation of multiwalled carbon nanotube cytotoxicity in cultures of human brain microvascular endothelial cells grown on plastic or basement membrane. Toxicol In Vitro 41:223-231

Showing the most recent 10 out of 89 publications